Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03612596
Other study ID # 17-0310
Secondary ID 1R21CA218543-01A
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date March 31, 2022

Study information

Verified date June 2023
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study tests the feasibility and acceptability of a physical activity intervention that combines use of a wearable activity monitor with a scrapbook. Half of the participants will receive this enhanced intervention, while the other half will receive a wearable activity monitor with a standard step log.


Description:

Women breast cancer survivors could benefit from increased physical activity but are in need of greater motivation to be active. Interventions that use wearable activity monitors and mobile apps have shown promise in the short-term, but use drops off over time. Reports have suggested that users find the step data provided to be unclear and not very personally meaningful. The ultimate purpose of this line of research is to test whether enhanced motivational feedback, using scrapbooks, can increase motivation for activity. The scrapbooks will target integrated regulation, which is a type of motivation related to personal identity and values. Participants who receive this intervention will draw their step graph, add photographs and stickers an explanations to the graph, and answer reflection questions daily. Before testing the effects of this intervention on physical activity, the investigators must first ensure that the materials and procedures are feasible and acceptable. This small pilot study will allow the research team to iteratively test scrapbook materials and improve upon them for use in future studies. The investigators will compare an intervention using the enhanced materials to an intervention using only the wearable device, app, and a standard step log without scrapbook or reflection components. In addition to the primary outcome of feasibility (use of the scrapbook), the investigators will also explore the effects of the intervention on steps, motivational and values-related outcomes, and various aspects of feasibility and acceptability.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date March 31, 2022
Est. primary completion date December 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 55 Years to 79 Years
Eligibility Inclusion Criteria: - Age between 55 and 79 years - Female - Self-reported diagnosis of breast cancer - BMI between 18 and 40 kg/m2 - Willingness to be randomized to any condition - Participant is able to walk for exercise - Able to read and understand English - Daily access to a smartphone or similar device compatible with Garmin app - PAR-Q+ indicates that physical activity would be safe (with note from physician required if any heart-related questions are endorsed) Exclusion Criteria: - Participant is active (150 minutes or more activity per week) - Major health interventions (surgery, radiation, chemo) within the past 6 months - Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months - History of orthopedic complications that would prevent optimal participation - No active recurrence of cancer - Self-reported smoker - Reports psychological issues that would interfere with study completion (dementia, schizophrenia) - Reports hospitalization within the past year due to psychiatric problem(s) - Plans to be out of town for more than 2 weeks at a time during study period - Clinical judgement concerning safety - Currently participating in an organized commercial or research exercise program - Another member of the household is a participant or staff member on this trial - Current use of a wearable activity monitor

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Narrative visualization
Participants use narrative visualization procedures to connect their step data to important events or feelings that occurred at the same time, then reflect on their behavior
Standard self-regulation
Participants self-monitor steps using a wearable device, app, and a hand-written step log

Locations

Country Name City State
United States The University of Texas Medical Branch Galveston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Receipt of Study Materials Self-reported percent of study materials received out of total supplied 12 weeks
Other Usefulness of Study Materials Self-reported usefulness of study materials, on a scale from 1 (strongly disagree they were useful) to 5 (strongly agree they were useful) 12 weeks
Other Participant Attrition Number of participants in each group who are lost to follow-up 24 weeks
Other Number of Serious Adverse Events The number of serious adverse events that occur during the intervention (0 - 12 weeks) and follow-up period (12 - 24 weeks) Up to 24 weeks
Other Days the Activity Monitor Was Worn The number of days the activity monitor was worn, as assessed via review of the mobile app 12 weeks
Other Completion of Values Clarification Activity From photographs taken of the intervention materials at the 12 week assessment, the investigators will assess whether participants in the enhanced intervention group completed their values clarification activity 12 weeks
Primary Percentage of Daily Workbook Entries Completed Percentage of daily workbook entries completed out of the total possible number, measured by photography of intervention materials at 12 week assessment and then assessment of each page. 12 weeks
Secondary Physical Activity as Measured by Steps Per Day During Intervention Period Mean of daily steps taken from accelerometers worn for 7 days Change from 0 to 12 weeks
Secondary Physical Activity as Measured by Daily Steps During No-intervention Maintenance Period Mean of steps per day taken from accelerometers worn for 7 days Change from 12 to 24 weeks
Secondary Intrinsic Regulation Self-reported intrinsic regulation on a scale from 0 (least motivated) to 4 (most motivated) using the Behavioral Regulation in Exercise Questionnaire - 3. Reported here are results from the intrinsic regulation subscale. Higher results on the scale indicate greater intrinsic regulation. Change from 0 to 12 weeks
Secondary Integrated Regulation Self-reported integrated regulation on a scale from 0 (least motivated) to 4 (most motivated) using the Behavioral Regulation in Exercise Questionnaire - 3. Here, results from the integrated regulation subscale are reported. Higher numbers on the scale indicate greater integrated regulation. Change from 0 to 12 weeks
Secondary Basic Psychological Needs: Autonomy Self-reported fulfillment of basic psychological needs on a scale from 1 (least fulfilled) to 5 (most fulfilled) using the Basic Psychological Needs in Exercise Questionnaire. The three subscales are perceived autonomy, competence, and relatedness. Here, autonomy is reported. A higher score means greater perceived autonomy. Change from 0 to 12 weeks
Secondary Exercise Identity Self-reported identity as an exerciser on a scale from 1 (strongly disagree) to 7 (strongly agree) as measured by the Exercise Identity Scale. The two subscales are exercise beliefs and exercise role identity. Here, exercise role identity is reported. A higher score means greater exercise role identity. Change from 0 to 12 weeks
Secondary Basic Psychological Needs: Competence Self-reported fulfillment of basic psychological needs on a scale from 1 (least fulfilled) to 5 (most fulfilled) using the Basic Psychological Needs in Exercise Questionnaire. The three subscales are perceived autonomy, competence, and relatedness. Here, competence is reported. A higher score means greater perceived competence. 0 to 12 weeks
Secondary Basic Psychological Needs: Relatedness Self-reported fulfillment of basic psychological needs on a scale from 1 (least fulfilled) to 5 (most fulfilled) using the Basic Psychological Needs in Exercise Questionnaire. The three subscales are perceived autonomy, competence, and relatedness. Here, relatedness is reported. A higher score means greater perceived relatedness. 0 to 12 weeks
Secondary Self-reflection Self-reported self-reflection on a scale from 1 (strongly disagree) to 5 (strongly agree) using the Self-Reflection and Insight Scale. Here, we report changes in the insight subscale, which has 8 items and a range of 5-40. For this scale, higher values indicate greater levels of insight. Change from 0 to 12 weeks
Secondary Quality of Life (Physical, Social, Emotional, Functional, and Breast Cancer-specific) Self-reported quality of life on a scale from 0 (not at all) to 4 (very much) using the Functional Assessment of Cancer Therapy - Breast measure. Reported here is the change in total score for the entire measure (with the total ranging from 0-123). Better quality of life is indicated by a lower score. Change from 0 to 12 weeks
Secondary Importance of Valued Domains Self-reported importance of family, intimate relationships, friends, work, health, and growth values domains on a scale from 0 (not at all important) to 5 (extremely important) using the Chronic Pain Values Inventory. Reported here is the change in total across all domains, which is an average of the individual items (range: 0-5). A higher score indicates stronger endorsement of importance of the valued domains. Change from 0 to 12 weeks
Secondary Success in Living According to Valued Domains Self-reported success in living according to values related to family, intimate relations, friends, work, health, and growth on a scale from 0 (not at all successful) to 5 (extremely successful) using the Chronic Pain Values Inventory. Reported here is the change in total across all domains, as an average across items (range: 0-5). A higher score indicates stronger endorsement of success in the valued domains. Change from 0 to 12 weeks
Secondary Engaged Living Self-reported perception of living in accordance with one's values on a scale from 1 (completely disagree) to 5 (completely agree) using the Engaged Living Scale. The two subscales are valued living and life fulfillment. Reported here is the change in total results for the scale (which ranges from 16-80). Higher scores on this scale indicate higher levels of engaged living. Change from 0 to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A